Published on in Vol 10, No 11 (2022): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37945, first published .
The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing

The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing

The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing

Deborah Chiavi   1 * , MSc ;   Christina Haag   1, 2 * , PhD ;   Andrew Chan   3 , MD ;   Christian Philipp Kamm   3, 4 , MD ;   Chloé Sieber   1, 2 , MSc ;   Mina Stanikić   1, 2 , MD ;   Stephanie Rodgers   1 , PhD ;   Caroline Pot   5 , MD ;   Jürg Kesselring   6 , MD ;   Anke Salmen   3 , MD ;   Irene Rapold   1 , PhD ;   Pasquale Calabrese   7 , MD ;   Zina-Mary Manjaly   8, 9 , MD ;   Claudio Gobbi   10, 11 , MD ;   Chiara Zecca   10, 11 , MD ;   Sebastian Walther   12 , MD ;   Katharina Stegmayer   12 , MD ;   Robert Hoepner   3 , MD ;   Milo Puhan   1 , PhD ;   Viktor von Wyl   1, 2 , PhD

1 Institute for Implementation Science in Health Care, University of Zurich, Zurich, Switzerland

2 Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland

3 Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland

4 Neurocenter, Lucerne Cantonal Hospital, Lucerne, Switzerland

5 Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

6 Department of Neurology and Neurorehabilitation, Rehabilitation Centre Kliniken Valens, Valens, Switzerland

7 Division of Molecular and Cognitive Neuroscience, University of Basel, Basel, Switzerland

8 Department of Neurology, Schulthess Klinik, Zurich, Switzerland

9 Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland

10 Multiple Sclerosis Center, Department of Neurology, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland

11 Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland

12 Translational Research Center, University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland

*these authors contributed equally

Corresponding Author:

  • Viktor von Wyl, PhD
  • Epidemiology, Biostatistics and Prevention Institute
  • University of Zurich
  • Hirschengraben 84
  • Zurich, 8001
  • Switzerland
  • Phone: 41 44 63 46380
  • Email: viktor.vonwyl@uzh.ch